{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe potency of angiotensin II antagonists is expressed as the IC50 which is the concentration of antagonist needed to displace 50% of the total specifically bound angiotensin II.\nFor the purposes of the present invention the preferred AII antagonists are compounds which are capable of inhibiting the action of AII by at least 50% at a concentration of 1mM or less, and especially preferred AII antagonists are compounds which are capable of inhibiting the action of AII by at least 50% at a concentration of 25nM or less when tested by the following standard methods.\nA particular fraction from rat mesenteric arteries is incubated in Tris buffer with 80 pM of 125I-angiotensin II with or without angiotensin II antagonists for 1 hour at 25\u00b0C."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "AII antagonists", "protein_target_name": "AII", "binding_metric": null, "value": "1mM", "unit": "mM", "is_logarithmic": false}, {"molecule_name": "AII antagonists", "protein_target_name": "AII", "binding_metric": null, "value": "25nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "125I-angiotensin II", "protein_target_name": null, "binding_metric": null, "value": "80", "unit": "pM", "is_logarithmic": false}]}
